[1]
Kumari, M. et al. 2025. Epicatechin as a potential hit to target ERK2 in breast cancer: molecular docking, molecular dynamic simulation studies. Journal of Integrated Science and Technology. 13, 4 (Jan. 2025), 1074. DOI:https://doi.org/10.62110/sciencein.jist.2025.v13.1074.